Prime Minister Narendra Modi on Saturday visited pharma major Zydus Cadila’s plant in Gujarat to take stock of the vaccine development process at the company’s research facility in Changodar industrial area.
Narendra Modi’s visit is part of his three-city tour to personally review the development of the coronavirus vaccine and the manufacturing process.
The PMO said the visit was to help him get a “first-hand perspective of the preparations, challenges, and roadmap in India’s endeavor to vaccinate its citizens”.
Zydus Cadila earlier announced that it was done with the first phase of the clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, and had commenced the second phase of clinical trials in August.
Modi will then go to Hyderabad to visit Bharat BioTech, which is working on Covaxin, India’s first indigenous vaccine candidate.
He will then proceed to Pune to be at Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and Oxford University for a COVID-19 vaccine.
The status will help Modi review the launch, production, and distribution mechanisms that may be needed for the vaccine.
“As India enters a decisive phase of the fight against COVID-19, PM Narendra Modi’s visit to these facilities and discussions with the scientists will help him get a first-hand perspective of the preparations, challenges, and roadmap in India’s endeavor to vaccinate its citizens,” the Prime Minister’s Office had earlier tweeted.
Narendra Modi met CMs virtually
Earlier Modi during a virtual meet with the chief ministers of various states to review the COVID-19 situation in the country advised the states to establish cold storage facilities for the COVID-19 vaccine beforehand.
He also asked them to be ready with a plan for the distribution of the same.
India reported 41,322 new COVID-19 cases on Saturday taking the total to over 93 lakh. The death toll stands at 1,36,200 so far.
To read the latest news in Gujarati click here